SBIR/STTR Research Award
Marine Mammal Vaccines
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2005Award details
- Awarding agency
- Department of Defense
- Branch
- Navy
- Recipient company
- Tetragenetics, Inc.
- Proposal award date
- 2005-07-05
- Contract end date
- 2006-04-04
- UEI
- E4V5EMGNKBY5
- Solicitation number
- 2004.1
- Topic code
- N04-117
Research abstract
Identify an animal model that shows clinical signs of disease. With such a model, we can begin to test the vaccine and obtain at least preliminary evidence for its efficacy. This would provide the impetus for Phase II studies, in which the vaccine will be tested more rigorously. We envisage that Phase II trials will investigate specific immune responses to the vaccine itself, along with levels of protection when administered by different routes (parenteral vs mucosal), in different vectors, and using prime-boost methodologies.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Expanding the use of Tetrahymena as a protein expression platform
- Novel methods for high-level expression of aglycosylated or fully glycosylated mo
- Genomes-To-Life (GTL) and Related Biotechnologies; Innovative Protein Production Technology in Microbes and Plants
- Genomes-To-Life (GTL) and Related Biotechnologies; Innovative Protein Production Technology in Microbes and Plants
- Tetrahymena thermophila as a Novel Recombinant and Engineered Protein Accumulation System (REPAS)
Research funding history
8 SBIR/STTR records share this UEI (2005–2015). Reported award amounts total $3,766,293. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, Department of Defense, Department of Energy